Showing 761-770 of 1319 results for "".
Dementia Insights: Antiamyloid Antibody Therapy in Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-antiamyloid-antibody-therapy-in-alzheimer-disease/31928/The saga continues for development of antiamyloid monoclonal antibodies, aducanumab, lecanemab, donanemab, and gantenerumab for Alzheimer disease.Cerebral Vasoconstriction and Vasospastic Angina Secondary to Pheochromocytoma
https://practicalneurology.com/diseases-diagnoses/headache-pain/cerebral-vasoconstriction-and-vasospastic-angina-secondary-to-pheochromocytoma/31979/This is the first reported case of pheochromocytoma associated with both RCVS and vasospastic angina in the same patient.Brain Imaging in Differential Diagnosis of Dementia
https://practicalneurology.com/diseases-diagnoses/imaging-testing/brain-imaging-in-differential-diagnosis-of-dementia/31533/Imaging biomarkers hold the promise of earlier diagnosis that may lead to more effective treatment.Emerging Therapies to Slow the Progression of Huntington Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/emerging-therapies-to-slow-the-progression-of-huntington-disease/31936/Although clinical trial results have been disappointing, they have moved development of potential disease-modifying treatments forward.Medical Marijuana and Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/medical-marijuana-and-movement-disorders/31951/Medical marijuana can be a useful tool for addressing nonmotor symptoms of movement disorders.Multiple Sclerosis in the Black Population of the United States
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-the-black-population-of-the-united-states/31756/Black people with multiple sclerosis are affected by frequent relapses, early disability accrual, and rapid disease progression.Sphingosine-1-Phosphate Modulators for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/sphingosine-1-phosphate-modulators-for-multiple-sclerosis/31629/Sphingosine-1-phosphate modulators may act through more than just inhibition of neuroimmune and neuroinflammatory effects of multiple sclerosis.Managing Mood Disorders, Behavioral Changes, and Psychosis in People Living with Vascular Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/managing-mood-disorders-behavioral-changes-and-psychosis-in-people-living-with-vascular-dementia/36649/This article explores the neuropsychiatric symptoms associated with vascular dementia, including their underlying mechanisms, clinical implications, and potential management strategies.Spotlight on Sleep: Beyond the Polysomnogram—Modern Approaches to Diagnosing Sleep Apnea
https://practicalneurology.com/diseases-diagnoses/sleep/beyond-the-polysomnogram-modern-approaches-to-diagnosing-sleep-apnea/35814/The evolution from in-laboratory polysomnography to flow-based home sleep apnea testing and, more recently, wearables reflects advancements in sleep technologies and a move toward patient-centered care.Telestroke & Telecritical Care
https://practicalneurology.com/diseases-diagnoses/imaging-testing/telestroke-telecritical-care/31745/Recent advances in telestroke and telecritical care have improved outcomes, although COVID-19 will have long-lasting effects on these services.